| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Chief Scientific Officer | Director +1 more
2 companies
Steven B Ketchum is Director at VIRX and has filed Form 4s across 2 companies. Steven B Ketchum's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $806K at current prices.
The biggest single holding is AMRN (~$514K) as EVP, Chief Scientific Officer. The AMRN filings lean toward selling, a net 2,426,850 shares.
Steven B Ketchum has 74 Form 4 filings on record from January 2015 to July 2026, across 2 companies: EVP, Chief Scientific Officer at Amarin (AMRN), 2015–2026; Director at Viracta Therapeutics (VIRX), 2015–2020.
The 277 reported transactions were 147 option exercises, 52 tax withholdings, 40 option or other derivative awards and 33 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $24.8M.
The largest open-market sale was 879,241 shares of AMRN at an average $11.10 on September 25, 2018, about $9.8M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sell10b5-1 | 34,131 | $0.79 | $26,963.49 | -5.7% | +13.5% | -40.4% | |
| Feb 1, 2021 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 217,728 | $8.06 | $1,754,133.55 | -36.2% | - | - | |
| Jan 27, 2021 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 421,629 | $8.01 | $3,378,131.34 | -52.1% | - | - | |
| Apr 30, 2019 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 9,541 | $18.67 | $178,106.62 | -2.6% | - | - | |
| Apr 1, 2019 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 9,542 | $20.06 | $191,391.99 | -2.6% | - | - | |
| Mar 1, 2019 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 55,543 | $21.85 | $1,213,524.05 | -13.5% | - | - | |
| Feb 1, 2019 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 37,530 | $17.17 | $644,372.89 | -9.6% | - | - | |
| Dec 31, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 17,041 | $13.51 | $230,211.98 | -4.8% | - | - | |
| Nov 30, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 17,042 | $17.79 | $303,173.77 | -4.8% | - | - | |
| Oct 31, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 17,042 | $20.74 | $353,453.86 | -4.8% | - | - |